Viral hepatitis: testing saves lives
Every year, around 50 000 newly diagnosed cases of hepatitis B and C are reported across Europe but millions are unaware of their infection. Left untreated, hepatitis can cause irreversible liver damage. Hepatitis A is recognised as a re-emerging health threat in Europe.
Assessment of HIV molecular surveillance capacity in the European Union, 2016
Keating, P., Pharris, A., Leitmeyer, K., De Angelis, S., Wensing, A., Amato-Gauci, A.J., Broberg, E.
Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
Hofstraat, S.H.I., Falla, A.M., Duffell, E.F., Hahné, S.J.M., Amato-Gauci, A.J., Veldhuijzen, I.K., Tavoschi, L.
Hepatitis E virus infection in Europe: Surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015
Aspinall, E.J., Couturier, E., Faber, M., Said, B., Ijaz, S., Tavoschi, L., Takkinen, J., Adlhoch, C.
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European centre for disease prevention and control (ECDC)’s 2010 HIV testing guidance
Sullivan, A.K., Sperle, I., Raben, D., Amato-Gauci, A.J., Lundgren, J.D., Yazdanpanah, Y., Jakobsen, S.F., Tavoschi, L.
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015
Jorgensen, P., Mereckiene, J., Cotter, S., Johansen, K., Tsolova, S., Brown, C.